NCT03474484View on ClinicalTrials.gov

Calprotectin I Serum as a Diagnostic Marker

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (1)

7006

Department of Thoracic and Occupational Medicine, Trondheim

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

lead

St. Olavs Hospital

OTHER

NCT03474484 - Calprotectin I Serum as a Diagnostic Marker | Biotech Hunter | Biotech Hunter